Presentation: 2024 ND EPSCoR Annual conference
November 21, 2024, Alerus Center, Grand Forks, North Dakota
Validating the use of the Biolog Mitochondrial Assay to Study Melatonin Toxicity
Ava
Wille
Undergraduate Student
Valley City State University
Co-author: Hilde van Gijssel, Science Professor, Valley City State University
Session
Poster Session B
Poster #39
E-cadherin plays an essential role in cell-cell connections. Loss of these connections is an important step in the transition of normal cells into cancer cells. The epithelial-mesenchymal transition (EMT) is the transition from a normal cell phenotype to metastatic cells that can grow without restrictions and invade other tissues. Loss of E-cadherin expression is a marker for EMT. Melatonin has been shown to increase E-cadherin expression in MCF7 breast cancer cells, and DU-145 prostate cancer cells. Research in our lab has shown that melatonin is toxic in concentration higher than 1 mM in these cells. The Biolog Mitochondrial Assays show how compounds affect mitochondrial function. This assay can be used to study toxicity of melatonin. In this study, we exposed DU-145 and MDA-MB-231 cells to melatonin concentrations between 3nM and 1mM. Mitochondrial function was followed for four hours using the Biolog Assay. Results show that melatonin does affect mitochondrial function in a dose dependent way.
The ND-ACES NSF Track-1 cooperative agreement is a federal-state partnership to manage a comprehensive research development plan. ND EPSCoR manages the Track-1 award. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the National Science Foundation. Current funding is provided by the State of North Dakota and NSF EPSCoR Research Infrastructure Improvement Program Track-1 (RII Track-1) Cooperative Agreement Award OIA #1946202.